We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Ironwood Pharmaceuticals
IRWD
$671M
| $11.3K | ﹤0.01% |
1,064
+359
| +51% | +$3.86K |
|
1827
Ranpak Holdings
PACK
$327M
| $11.2K | ﹤0.01% |
2,474
-862,782
| -100% | -$3.43M |
|
1828
Steven Madden
SHOO
$2.96B
| $11.1K | ﹤0.01% |
339
-91
| -21% | -$3.03K |
|
|
AD
1829
Array Digital Infrastructure
AD
$3.29B
| $10.9K | ﹤0.01% |
621
-543
| -47% | -$9.68K |
|
1830
Preformed Line Products
PLPC
$1.97B
| $10.9K | ﹤0.01% |
70
-14
| -17% | -$2.04K |
|
1831
Factset
FDS
$9.85B
| $10.8K | ﹤0.01% |
27
-176
| -87% | -$71K |
|
1832
Titan International
TWI
$463M
| $10.7K | ﹤0.01% |
931
-24,415
| -96% | -$259K |
|
1833
ANI Pharmaceuticals
ANIP
$1.66B
| $10.6K | ﹤0.01% |
+197
| New | +$8.73K |
|
1834
LeMaitre Vascular
LMAT
$1.84B
| $10.5K | ﹤0.01% |
156
-137
| -47% | -$8.36K |
|
1835
Powell Industries
POWL
$6.24B
| $10.5K | ﹤0.01% |
519
+96
| +23% | +$1.66K |
|
1836
Baytex Energy
BTE
$3.61B
| $10.5K | ﹤0.01% |
+3,213
| New | +$11.3K |
|
1837
Lucid Motors
LCID
$1.62B
| $10.2K | ﹤0.01% |
148
+36
| +32% | +$2.57K |
|
1838
Zebra Technologies
ZBRA
$16.2B
| $10.1K | ﹤0.01% |
34
-338
| -91% | -$94.8K |
|
1839
Covenant Logistics
CVLG
$915M
| $9.86K | ﹤0.01% |
450
-10
| -2% | -$193 |
|
|
CMRX
1840
DELISTED
Chimerix, Inc.
CMRX
| $9.78K | ﹤0.01% |
8,086
-669
| -8% | -$848 |
|
1841
Bread Financial
BFH
$4.14B
| $9.7K | ﹤0.01% |
309
-15,204
| -98% | -$437K |
|
1842
Signet Jewelers
SIG
$3.83B
| $9.66K | ﹤0.01% |
148
-105
| -42% | -$7.27K |
|
1843
CMS Energy
CMS
$20.7B
| $9.28K | ﹤0.01% |
158
-20
| -11% | -$1.21K |
|
1844
Wabash National
WNC
$509M
| $9.28K | ﹤0.01% |
362
+153
| +73% | +$3.76K |
|
1845
Crawford & Co Class B
CRD.B
$554M
| $9.18K | ﹤0.01% |
+978
| New | +$8.33K |
|
|
BFX
1846
DELISTED
BowFlex Inc.
BFX
| $9.14K | ﹤0.01% |
7,493
-2,729
| -27% | -$3.47K |
|
1847
DaVita
DVA
$12.2B
| $9.04K | ﹤0.01% |
90
-1,319
| -94% | -$122K |
|
1848
Prudential
PUK
$32.8B
| $8.89K | ﹤0.01% |
314
+21
| +7% | +$601 |
|
|
TAST
1849
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $8.88K | ﹤0.01% |
+1,762
| New | +$7.98K |
|
1850
Hanmi Financial
HAFC
$954M
| $8.63K | ﹤0.01% |
578
| – | – |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.